Published in Arch Biochem Biophys on December 01, 1983
Down regulation of epidermal growth factor receptors: direct demonstration of receptor degradation in human fibroblasts. J Cell Biol (1984) 2.12
Elevated content of the tyrosine kinase substrate phospholipase C-gamma 1 in primary human breast carcinomas. Proc Natl Acad Sci U S A (1991) 1.77
Stimulation of glycolysis and amino acid uptake in NRK-49F cells by transforming growth factor beta and epidermal growth factor. Proc Natl Acad Sci U S A (1985) 1.51
Perinuclear location and recycling of epidermal growth factor receptor kinase: immunofluorescent visualization using antibodies directed to kinase and extracellular domains. J Cell Biol (1986) 1.09
Stimulation of glucose uptake by transforming growth factor beta: evidence for the requirement of epidermal growth factor-receptor activation. Proc Natl Acad Sci U S A (1985) 1.07
Epidermal growth factor signaling and mitogenesis in Plcg1 null mouse embryonic fibroblasts. Mol Biol Cell (1998) 1.04
Epidermal growth factor-nonresponsive 3T3 variants do not contain epidermal growth factor receptor-related antigens or mRNA. Proc Natl Acad Sci U S A (1986) 0.98
Epidermal growth factor receptor distribution in burn wounds. Implications for growth factor-mediated repair. J Clin Invest (1992) 0.98
Epidermal growth factor receptors in idiopathic and virally induced skin diseases. Am J Pathol (1992) 0.87
Non-catalytic activation of phospholipase C-gamma 1 in vitro by epidermal growth factor receptor. Biochem J (1993) 0.85
Epidermal growth factor stimulates substrate-selective protein-tyrosine-phosphatase activity. Proc Natl Acad Sci U S A (1993) 0.85
Activity of the epidermal-growth-factor receptor and phospholipase C-gamma 1 in heat-stressed fibroblasts and A-431 cells. Biochem J (1992) 0.75
Epidermal growth factor. Annu Rev Biochem (1979) 11.82
125I-labeled human epidermal growth factor. Binding, internalization, and degradation in human fibroblasts. J Cell Biol (1976) 10.88
Receptors for epidermal growth factor and other polypeptide mitogens. Annu Rev Biochem (1987) 5.57
Epidermal growth factor-receptor-protein kinase interactions. Co-purification of receptor and epidermal growth factor-enhanced phosphorylation activity. J Biol Chem (1980) 5.19
Quantitation of protein. Methods Enzymol (1990) 5.00
gamma -Secretase cleavage and nuclear localization of ErbB-4 receptor tyrosine kinase. Science (2001) 4.90
Increase of the catalytic activity of phospholipase C-gamma 1 by tyrosine phosphorylation. Science (1990) 4.36
Human epidermal growth factor and the proliferation of human fibroblasts. J Cell Physiol (1976) 3.91
Epidermal growth factor stimulates phosphorylation in membrane preparations in vitro. Nature (1978) 3.54
Characterization of the binding of 125-I-labeled epidermal growth factor to human fibroblasts. J Biol Chem (1975) 3.48
Rapid enhancement of protein phosphorylation in A-431 cell membrane preparations by epidermal growth factor. J Biol Chem (1979) 3.18
Epidermal growth factor stimulates tyrosine phosphorylation of phospholipase C-II independently of receptor internalization and extracellular calcium. Proc Natl Acad Sci U S A (1989) 3.17
Human epidermal growth factor: isolation and chemical and biological properties. Proc Natl Acad Sci U S A (1975) 2.95
All ErbB receptors other than the epidermal growth factor receptor are endocytosis impaired. J Biol Chem (1996) 2.84
Platelet-derived growth factor induces rapid and sustained tyrosine phosphorylation of phospholipase C-gamma in quiescent BALB/c 3T3 cells. Mol Cell Biol (1989) 2.78
Antiphosphotyrosine recovery of phospholipase C activity after EGF treatment of A-431 cells. Science (1988) 2.62
Interaction of activated EGF receptors with coated pit adaptins. Science (1993) 2.42
Down regulation of epidermal growth factor receptors: direct demonstration of receptor degradation in human fibroblasts. J Cell Biol (1984) 2.12
Essential role of the tyrosine kinase substrate phospholipase C-gamma1 in mammalian growth and development. Proc Natl Acad Sci U S A (1997) 1.90
Acrocephaly, with other Congenital Malformations-Autopsy. Proc R Soc Med (1909) 1.89
Interaction of epidermal growth factor (EGF) with cultured fibroblasts. Adv Metab Disord (1975) 1.88
Elevated content of the tyrosine kinase substrate phospholipase C-gamma 1 in primary human breast carcinomas. Proc Natl Acad Sci U S A (1991) 1.77
Tyrosine residues in bovine phospholipase C-gamma phosphorylated by the epidermal growth factor receptor in vitro. J Biol Chem (1990) 1.75
Glycosylation of the epidermal growth factor receptor in A-431 cells. The contribution of carbohydrate to receptor function. J Biol Chem (1984) 1.62
Transforming growth factor alpha and beta expression in human colon cancer lines: implications for an autocrine model. Cancer Res (1987) 1.61
Tyrosine phosphorylation of phospholipase C-II in vitro by the epidermal growth factor receptor. J Biol Chem (1989) 1.60
Stoichiometric interaction of the epidermal growth factor receptor with the clathrin-associated protein complex AP-2. J Biol Chem (1995) 1.57
Effect of enteral and parenteral feeding in malnourished rats with E. coli-hemoglobin adjuvant peritonitis. J Surg Res (1981) 1.57
Altered [125I]epidermal growth factor binding and receptor distribution in psoriasis. J Invest Dermatol (1986) 1.56
Congenital Morbus cordis-Patent Ductus arteriosus; Aortic Valves Bicuspid; Right Heart dwarfed. Proc R Soc Med (1909) 1.56
Electrophoretic variation in adenylate kinase of Neisseria meningitidis is due to inter- and intraspecies recombination. Proc Natl Acad Sci U S A (1995) 1.48
Antibodies to the epidermal growth factor receptor block the biological activities of sarcoma growth factor. Proc Natl Acad Sci U S A (1983) 1.48
Identification of two epidermal growth factor-sensitive tyrosine phosphorylation sites of phospholipase C-gamma in intact HSC-1 cells. J Biol Chem (1990) 1.47
Enteral and parenteral feeding influences mortality after hemoglobin-E. coli peritonitis in normal rats. J Trauma (1983) 1.47
Mapping of the molecular determinants involved in the interaction between eps15 and AP-2. Cancer Res (1997) 1.46
Focal adhesion kinase promotes phospholipase C-gamma1 activity. Proc Natl Acad Sci U S A (1999) 1.46
The carboxyl terminus of epidermal growth factor receptor/erbB-2 chimerae is internalization impaired. Oncogene (1993) 1.44
The role of individual SH2 domains in mediating association of phospholipase C-gamma1 with the activated EGF receptor. J Biol Chem (1999) 1.43
Feedback regulation of phospholipase C-beta by protein kinase C. J Biol Chem (1990) 1.41
Role of epidermal growth factor in carcinogenesis. Cancer Res (1986) 1.41
Regulation of epidermal growth factor-stimulated formation of inositol phosphates in A-431 cells by calcium and protein kinase C. J Biol Chem (1988) 1.41
Patient-validated content of epilepsy-specific quality-of-life measurement. Epilepsia (1997) 1.41
Constitutive expression of insulin-like growth factor 1 and insulin-like growth factor 1 receptor abrogates all requirements for exogenous growth factors. Cell Growth Differ (1992) 1.41
Vocal cord dysfunction during wartime. Mil Med (1992) 1.39
Selective cleavage of the heregulin receptor ErbB-4 by protein kinase C activation. J Biol Chem (1996) 1.36
Epidermal growth factor is a major growth-promoting agent in human milk. Science (1980) 1.35
Multiple autophosphorylation site mutations of the epidermal growth factor receptor. Analysis of kinase activity and endocytosis. J Biol Chem (1991) 1.34
Characterization by electrophoresis of epidermal growth factor stimulated phosphorylation using A-431 membranes. Biochemistry (1980) 1.31
Stimulation of phospholipase C-gamma 1 membrane association by epidermal growth factor. Science (1990) 1.29
Growth factor stimulation of phospholipase C-gamma 1 activity. Comparative properties of control and activated enzymes. J Biol Chem (1992) 1.28
Letter: Chloramphenicol eye-drops and marrow aplasia. Lancet (1975) 1.27
Epidermal growth factor, its receptor, and related proteins. Exp Cell Res (1986) 1.27
Physiological requirement for both SH2 domains for phospholipase C-gamma1 function and interaction with platelet-derived growth factor receptors. Mol Cell Biol (1999) 1.26
Epidermal growth factor activation of NF-kappaB is mediated through IkappaBalpha degradation and intracellular free calcium. Oncogene (1998) 1.24
Properties of the receptor for epidermal growth factor. Cell (1984) 1.23
Immunolocalization of epidermal growth factor receptors in normal developing human skin. J Invest Dermatol (1990) 1.23
Disruption of the interaction of mammalian protein synthesis eukaryotic initiation factor 4B with the poly(A)-binding protein by caspase- and viral protease-mediated cleavages. J Biol Chem (2001) 1.22
Geldanamycin induces ErbB-2 degradation by proteolytic fragmentation. J Biol Chem (2000) 1.22
Individual epidermal growth factor receptor autophosphorylation sites do not stringently define association motifs for several SH2-containing proteins. J Biol Chem (1994) 1.22
Production and characterization of antibody blocking epidermal growth factor:receptor interactions. Biochim Biophys Acta (1980) 1.21
Epidermal growth factor (EGF) stimulates inositol trisphosphate formation in cells which overexpress the EGF receptor. Biochem Biophys Res Commun (1987) 1.20
Constitutive proteolysis of the ErbB-4 receptor tyrosine kinase by a unique, sequential mechanism. J Cell Biol (1997) 1.20
Heregulin-dependent trafficking and cleavage of ErbB-4. J Biol Chem (2000) 1.18
Dimerization of internalized epidermal growth factor receptors. J Biol Chem (1991) 1.18
The biochemistry and physiology of the receptor-kinase for epidermal growth factor. Mol Cell Endocrinol (1983) 1.17
The ErbB-4 s80 intracellular domain is a constitutively active tyrosine kinase. Oncogene (2006) 1.16
Interspecies recombination in nature: a meningococcus that has acquired a gonococcal PIB porin. Mol Microbiol (1995) 1.15
Oxidative stress-induced phospholipase C-gamma 1 activation enhances cell survival. J Biol Chem (2001) 1.15
Comparison of epidermal growth factor binding and receptor distribution in normal human epidermis and epidermal appendages. J Invest Dermatol (1984) 1.14
Epidermal growth factor receptor: elements of intracellular communication. J Membr Biol (1992) 1.13
The oligosaccharide moieties of the epidermal growth factor receptor in A-431 cells. Presence of complex-type N-linked chains that contain terminal N-acetylgalactosamine residues. J Biol Chem (1985) 1.13
EGF receptor antiserum inhibits bone resorbing activity produced by a rat Leydig cell tumor associated with the humoral hypercalcemia of malignancy. Endocrinology (1985) 1.11
Influence of lectins on the binding of 125I-labeled EGF to human fibroblasts. Biochem Biophys Res Commun (1977) 1.09
SH2 domain-mediated activation of phospholipase Cgamma is not required to initiate Ca2+ release at fertilization of mouse eggs. Dev Biol (1998) 1.08
The regulation of phospholipase C-gamma 1 by phosphatidic acid. Assessment of kinetic parameters. J Biol Chem (1993) 1.08
Elimination of new chronic hepatitis B virus infections: results of the Alaska immunization program. J Infect Dis (2000) 1.06
Functional and structural characteristics of EGF and its receptor and their relationship to transforming proteins. J Cell Biochem (1986) 1.06
The regulation of cell proliferation: advances in the biology and mechanism of action of epidermal growth factor. J Invest Dermatol (1978) 1.06
The EGF/TGF alpha receptor in skin. J Invest Dermatol (1990) 1.06
Heregulin degradation in the absence of rapid receptor-mediated internalization. Exp Cell Res (1997) 1.05
Protein assay sensitive at nanogram levels. Anal Biochem (1987) 1.05
Rate constants for binding, dissociation, and internalization of EGF: effect of receptor occupancy and ligand concentration. Biochemistry (1990) 1.04
Epidermal growth factor signaling and mitogenesis in Plcg1 null mouse embryonic fibroblasts. Mol Biol Cell (1998) 1.04
Characterization of the metabolic turnover of epidermal growth factor receptor protein in A-431 cells. J Cell Physiol (1984) 1.04
Interaction of the adaptor protein Shc and the adhesion molecule cadherin. J Biol Chem (1997) 1.03
Epidermal growth factor/transforming growth factor alpha receptors and psoriasis. J Invest Dermatol (1990) 1.01
Solubilization of membrane receptor for epidermal growth factor. Life Sci (1979) 1.01
Phospholipase C-gamma1: regulation of enzyme function and role in growth factor-dependent signal transduction. Cytokine Growth Factor Rev (1997) 1.00
Analysis of the influences of the E5 transforming protein on kinetic parameters of epidermal growth factor binding and metabolism. J Cell Physiol (1992) 0.99
Tyrosine phosphorylation of ras GTPase-activating protein does not require association with the epidermal growth factor receptor. J Biol Chem (1993) 0.99
Localization of immunoreactive epidermal growth factor receptors in human nervous system. J Histochem Cytochem (1988) 0.98
Biology of the A-431 cell: a useful organism for hormone research. J Cell Biochem (1983) 0.98
Binding assays for epidermal growth factor. Methods Enzymol (1985) 0.98
Selective phospholipase C activation. Bioessays (1991) 0.97
Polysomnographic findings in recently drug-free and clinically remitted depressed patients. Arch Gen Psychiatry (1986) 0.97